CrossRef

Efficacy of cefiderocol and levofloxacin against Stenotrophomonas maltophilia in a hemorrhagic pneumonia mouse model

Antimicrobial Agents and Chemotherapy 70(3) (2026)

Waki Imoto; Junko Abe; Norihiro Sakurai; Kengo Kawamoto; Koichi Yamada; Yukihiro Kaneko; Hiroshi Kakeya; Anne-Catrin Uhlemann

Clinical Characteristics and Prognostic Factors of Patients With Stenotrophomonas maltophilia Pneumonia: 10-Year Experience From a Single Center

Cureus (2023)

Deniz Kızılırmak; Yavuz Havlucu

Fluoroquinolones versus trimethoprim-sulfamethoxazole for the treatment of Stenotrophomonas maltophilia infections: a systematic review and meta-analysis

Clinical Microbiology and Infection 25(5) (2019)

J.-H. Ko; C.-I. Kang; P. Cornejo-Juárez; K.-M. Yeh; C.-H. Wang; S.Y. Cho; M.G. Gözel; S.-H. Kim; P.-R. Hsueh; N. Sekiya; Y. Matsumura; D.-G. Lee; S.-Y. Cho; S. Shiratori; Y.-J. Kim; D.R. Chung; K.R. Peck

Prevalence and Antibiotic Resistance of Stenotrophomonas maltophilia in Respiratory Tract Samples: A 10-Year Epidemiological Snapshot

Health Services Research and Managerial Epidemiology 6 (2019)

Márió Gajdács; Edit Urbán

Untitled

In which cases of pneumonia should we consider treatments for Stenotrophomonas maltophilia?

Journal of Hospital Infection 111 (2021)

W. Imoto; K. Yamada; G. Kuwabara; K. Yamairi; W. Shibata; K. Oshima; K. Nakaie; T. Watanabe; K. Asai; Y. Kaneko; T. Kawaguchi; H. Kakeya

Potential application of a newly isolated phage BUCT609 infecting Stenotrophomonas maltophilia

Frontiers in Microbiology 13 (2022)

Ke Han; Yuqi Dong; Xiaoping An; Lihua Song; Mengzhe Li; Huahao Fan; Yigang Tong

Antibiotic resistance in the Middle East and Southern Asia: a systematic review and meta-analysis

JAC-Antimicrobial Resistance 7(1) (2024)

Rachel Mathu; Elizabeth Diago-Navarro; Emily Lynch; Marie-Amélie Degail; Janet Ousley; Rupa Kanapathipillai; Justine Michel; Marc Gastellu-Etchegorry; Nada Malou

Untitled